TSSIMarch 11, 2026 at 11:00 AM UTCFinancial Services

TSS Reports Robust 2025 Growth but Execution Hurdles Linger

Read source article

What happened

TSS announced full-year 2025 revenue of $246 million, up 66%, and diluted EPS of $0.56, up 133%, exceeding its outlook with CEO Darryll Dewan citing a ramp in systems integration volumes at the new Georgetown facility in Q4. This growth follows a volatile Q3 2025, where revenue dropped 40% year-over-year and margins compressed to 13% in systems integration, leading to a net loss as highlighted in the DeepValue report. The company remains almost entirely dependent on Dell for revenue, with 99% concentration amplifying risks from AI capex cycles and procurement volatility. Georgetown's ramp is critical for absorbing fixed costs and improving margins, but it must overcome underutilization and dual-site rent from the old Round Rock facility. Despite the strong full-year numbers, TSS has yet to prove it can sustain GAAP profitability and achieve mid-teens consolidated gross margins without further dilution.

Implication

The revenue and EPS growth confirm TSS's leverage to AI demand, yet the stock trades at 51x trailing earnings, pricing in near-perfect execution without margin for error. Georgetown's Q4 ramp is encouraging but needs to lift systems integration margins from 13% toward mid-20s%+ to justify the facility's fixed costs and debt service. Customer concentration with Dell means any slowdown in AI server orders or contract renegotiation could swiftly derail the growth story, as seen in Q3's volatility. Investors must monitor upcoming quarters for consecutive GAAP-profitable periods and gross margin expansion to at least 15% to validate the economic model. Until then, the risk/reward favors patience, with the DeepValue report's attractive entry near $8 offering better downside protection than buying at current levels.

Thesis delta

The new results do not alter the core investment thesis; growth is on track, but the critical barriers of margin sustainability, customer concentration, and profitability without dilution remain unchanged. Investors should maintain a 'WAIT' stance, as the thesis requires evidence of two consecutive GAAP-profitable quarters with improved margins before considering an upgrade.

Confidence

High